Clinical Decision Support Tool to Enhance Angiotensin-Converting Enzyme Inhibitor (ACEI)/Angiotensin Receptor Blocker (ARB) Use in Patients with CKD

Sankar D. Navaneethan(Baylor College of Medicine), Michael E. Matheny(Department of Veterans Affairs), Michael A. Herrera(Baylor College of Medicine), L. Parker Gregg(Baylor College of Medicine), Dax Westerman(Vanderbilt University Medical Center), Peter J. Richardson(BenevolentAI (United Kingdom)), Glenn T. Gobbel(Valley Health System), Mohammed Ali Al-Garadi(Vanderbilt University Medical Center), Sheena Wydermyer(United States Department of Veterans Affairs), Salim S. Virani(Aga Khan University)
Journal of the American Society of Nephrology
October 1, 2025
10.1681/asn.2025g90kcsy9
Cited by 0

Related Papers

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|6.2k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k